Glucocorticoid‐induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine‐induced COX‐2 expression
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Cyclooxygenase‐2 (COX‐2) plays an important role in rheumatoid arthritis and therefore, has been a major target for anti‐arthritis therapies. The expression of COX‐2 is induced by inflammatory cytokines such as TNF‐α and IL‐1β, and inhibited by glucocorticoids. However, the molecular mechanisms underlying the anti‐inflammatory and immune suppressive actions of glucocorticoids are not well defined. Here we report that glucocorticoid‐induced leucine zipper (GILZ) mimics glucocorticoid action and inhibits inflammatory cytokine‐induced COX‐2 expression in bone marrow mesenchymal stem cells, the cells that have been recently implicated in the pathogenesis and progression of rheumatoid arthritis. Using a retrovirus‐mediated gene expression approach we demonstrate that overexpression of GILZ inhibits TNF‐α and IL‐1β‐induced COX‐2 mRNA and protein expression, and knockdown of GILZ by shRNA reduces glucocorticoid inhibition of cytokine‐induced COX‐2 expression. Consistent to these results, overexpression of GILZ also inhibits NF‐κB‐mediated COX‐2 promoter activity. Finally, we show that GILZ inhibits COX‐2 expression by blocking NF‐κB nuclear translocation. Our results suggest that GILZ is a key glucocorticoid effect mediator and that GILZ may have therapeutic value for novel anti‐inflammation therapies. J. Cell. Biochem. 103: 1760–1771, 2008. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918 · cited 1×
“…functional NF-kB binding sites and is known to be activated by NF-kB through this site in response to cytokines [Wadleigh and Herschman, 1999; Tak and Firestein, 2001]; and (3) MSCs have been recently implicated in the pathogenesis of rheumatoid arthritis [Li and Makarov, 2006], and…”
BackgroundAuphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390 · cited 1×
“GCs are known to counteract the key inflammatory signaling mediators, NF-kB and AP-1, through a mechanism involving the GC receptors (GRs) [Auphan et al., 1995; De Bosscher et al., 2003].”
BackgroundYang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553 · cited 1×
“This, most likely, is due to the induction of endogenous GILZ (middle panel) and the activation of GC receptors (GRs) by Dex, an event that is known to inhibit NF-kB and AP-1 transcriptional activities [Yang-Yen et al., 1990; Ray and Prefontaine, 1994].”
BackgroundDe Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898 · cited 1×
“GCs are known to counteract the key inflammatory signaling mediators, NF-kB and AP-1, through a mechanism involving the GC receptors (GRs) [Auphan et al., 1995; De Bosscher et al., 2003].”
BackgroundD'Adamio, F., Zollo, O., Moraca, R., Ayroldi, E., Bruscoli, S., Bartoli, A., Cannarile, L., Migliorati, G., & Riccardi, C. (1997) · Immunity · doi:10.1016/s1074-7613(00)80398-2 · Cited by 444 · cited 2×
“Importantly, most of, if not all, the published studies were carried out in the presence of GCs, and it is now known that these also induce GILZ [D’Adamio et al., 1997; Cannarile et al., 2001], which had not been identified at that time, and GILZ also interacts with NF-kB and AP-1.”
BackgroundDe Bosscher, K. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00297-6 · Cited by 264
Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids
Almawi, W., & Melemedjian, O. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280069 · Cited by 242
Cohen, N., Mouly, E., Hamdi, H., Maillot, M.-C., Pallardy, M., Godot, V., Capel, F., Balian, A., Naveau, S., Galanaud, P., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2760 · Cited by 170
Cited by
Immune regulation by glucocorticoids
Cain, D. W., & Cidlowski, J. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.1 · Cited by 1,846
Glucocorticoid‐induced leucine zipper (GILZ): a new important mediator of glucocorticoid action
Ayroldi, E., & Riccardi, C. (2009) · The FASEB Journal · doi:10.1096/fj.09-134684 · Cited by 338
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Swindell, W. R. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-585 · Cited by 171
Dynamic regulation of glucocorticoid signalling in health and disease
Biddie, S. C., Conway-Campbell, B. L., & Lightman, S. L. (2012) · Rheumatology · doi:10.1093/rheumatology/ker215 · Cited by 143
Metadata
- Authors
- Yang, N., Zhang, W., & Shi, X.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2007-10
- Volume
- 103
- Issue
- 6
- Pages
- 1760-1771
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2142273574
- Cited by
- 73
- References
- 8
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucocorticoid‐induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine‐induced COX‐2 expression. https://app.cochat.ai/papers/10.1002/jcb.21562
- The paper
- Yang, N., Zhang, W., & Shi, X. (2008). Glucocorticoid‐induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine‐induced COX‐2 expression. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.21562
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.